Dr. Anthony Deo is an Assistant Professor in the Department of Psychiatry at the Rutgers Robert Wood Johnson Medical School. He is a Child and Adolescent Psychiatrist with a specific interest in the underlying neurodevelopmental pathology contributing to childhood and adolescent onset psychosis. His research has been multifaceted, utilizing genetic, computational and cellular approaches.

He earned his Ph.D. in Biology from New York University under the mentorship of Fatemeh Haghighi, Ph.D. and Rob DeSalle, Ph.D. Supported by an NSF Doctoral Dissertation Improvement Grant, he developed an algorithm to identify genetic loci linked to subsets of symptoms in psychiatric disorders disregarding diagnostic categories supported. He then completed his M.D. and a Certificate in Clinical Research at the University of Pittsburgh School of Medicine’s competitive five-year Physician Scientist Training Program. His research, under the mentorship of Rob Sweet, M.D. and David Lewis, M.D and supported by a Doris Duke Foundation Clinical Research Fellowship, focused on molecular signaling pathways that contribute to the disruption of auditory sensory processing in schizophrenia. Following completion of his Adult and Child and Adolescent Psychiatry Residency training programs at Columbia University / Cornell University and New York Presbyterian Hospital he completed research fellowship training at the Broad Institute where he was involved in a project utilizing human induced pluripotent stem cell cerebral organoid models to study early neurodevelopmental changes contributing to the onset of autism spectrum disorders.

Simultaneously, he joined the faculty at Harvard Medical School as an Instructor in Psychiatry and Tommy Fuss Center Fellow in Neuropsychiatric Disease at Boston Children’s Hospital. He had the unique experience of clinically treating and conducting research with children as young as 6 years old with psychosis at the Developmental Neuropsychiatry Clinic at Boston Children’s Hospital. Recognizing a need to treat and better understand this underserved population, he created and served as the Director of the Psychiatric Evaluation of Adolescent and Child Experiences (PEACE) Clinic, an early onset psychosis clinical and research program at Rutgers. The goal of his research program is to identify clinically relevant and accessible biomarkers to predict the course of early onset psychosis including recently using natural language processing to identify language biomarkers.

During his KL2 award he will be working with Carlos Pato, M.D., Ph.D. and David Zald, Ph.D. on a project utilizing natural language processing to identify language biomarkers unique to childhood onset psychosis.